Of interest, Churchman et al. demonstrated reversal of this phenomenon in IKZF1-aberrant BCR-ABL ALL by treatment with retinoid receptor agonists, thereby suggesting a possible therapeutic avenue for IKZF1del leukemias [140]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.